Prostate Cancer - Results from #21420

Metastatic castration-resistant prostate cancer (CRPC): Preclinical and clinical evidence for the sequential use of novel therapeutics - Abstract February 21, 2014

Enzalutamide (Xtandi) for patients with metastatic, resistant prostate cancer - Abstract February 21, 2014

Role of endorectal MR imaging and MR spectroscopic imaging in defining treatable intraprostatic tumor foci in prostate cancer: Quantitative analysis of imaging contour compared to whole-mount histopathology - Abstract February 19, 2014

Oral etoposide and oral prednisone for the treatment of castration resistant prostate cancer - Abstract February 19, 2014

Less satisfaction with information in patients with prostate cancer treated with surgery and salvage radiotherapy compared with patients treated with curative radiotherapy alone, despite similar health-related quality of life - Abstract February 19, 2014

Detection of the index tumor and tumor volume in prostate cancer using T2w and DW MRI alone - Abstract February 19, 2014

Comparison of high-dose (86.4 Gy) IMRT vs combined brachytherapy plus IMRT for intermediate-risk prostate cancer - Abstract February 19, 2014

Diagnostic value of biparametric MRI as an adjunct to PSA-based detection of prostate cancer in men without prior biopsies - Abstract February 19, 2014

Three-dimensional surgical navigation model with Tile-Pro display during robotic radical prostatectomy - Abstract February 19, 2014

Accuracy of multiparametric MRI for prostate cancer detection: A meta-analysis - Abstract February 19, 2014

Standards for prostate biopsy - Abstract February 19, 2014

Low prostate concentration of lycopene is associated with development of prostate cancer in patients with high-grade prostatic intraepithelial neoplasia - Abstract February 19, 2014

3D ultrasound guidance for prostate biopsy with MRI-image fusion - Abstract February 19, 2014

Role of multiparametric 3.0 tesla magnetic resonance imaging for decision-making to preserve or resect neurovascular bundles at robotic assisted laparoscopic radical prostatectomy - Abstract February 19, 2014

Randomized controlled trial of early removal of urethral catheter with suprapubic tube drainage versus urethral catheter drainage alone following robot-assisted laparoscopic radical prostatectomy - Abstract February 19, 2014

Disease control outcomes from analysis of pooled individual patient data from five comparative randomised clinical trials of degarelix versus luteinising hormone-releasing hormone agonists - Abstract February 19, 2014

Incidence of complications other than urinary incontinence or erectile dysfunction after radical prostatectomy or radiotherapy for prostate cancer: A population-based cohort study - Abstract February 19, 2014

Long-term outcomes following radiation therapy for prostate cancer patients with lymph node metastases at diagnosis treated with and without surgery - Abstract February 18, 2014

Rituximab for treating CD20+ prostate cancer with generalized lymphadenopathy: A case report and review of the literature - Abstract February 18, 2014

Is prostate cancer screening cost-effective? A microsimulation model of prostate-specific antigen-based screening for British Columbia, Canada - Abstract February 18, 2014

Page 1072 of 1447